Kaneka (4118) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Aug, 2026Executive summary
Net sales reached ¥807.2 billion for FY2024, up 5.9% year-over-year, with increases in all business segments.
Operating income rose 22.9% to ¥40.1 billion, and net income grew 9.0% to ¥25.3 billion year-over-year.
All four business segments posted year-over-year increases in both sales and profits, with notable growth in Leading-edge Businesses and steady performance in Foundation Businesses.
Profitability improved, with operating income margin at 5.0% and ROE at 5.5%.
Dividend per share increased to ¥130, with a progressive dividend policy planned.
Financial highlights
Net sales: ¥807.2 billion (YOY +5.9%).
Operating income: ¥40.1 billion (YOY +22.9%).
Net income: ¥25.3 billion (YOY +9.0%).
Net income per share: ¥400.91; dividend per share: ¥130.
Equity ratio: 51.2%; debt/equity ratio: 0.43.
Outlook and guidance
FY2025/2026 forecast: net sales ¥820.0 billion (+1.6%), operating income ¥42.0 billion (+4.9%), net income ¥33.0 billion (+30.4%).
Dividend per share planned at ¥160 (+¥30 YOY); treasury share repurchase up to 3 million shares.
Focus on capital efficiency, business portfolio transformation, and local production.
Forecasts do not factor in potential negative impacts from new U.S. reciprocal tariffs due to uncertainty.
Latest events from Kaneka
- Strong sales and profit growth across all segments, with robust outlook and higher dividends.4118
Q1 2025 - Operating income surged 51.5% year-over-year, led by strong growth in core segments.4118
Q2 2025 - Record sales and profits led to upward revisions in earnings and dividend forecasts.4118
Q3 2025 - Profits fell despite higher sales, but a rebound is expected as market conditions improve.4118
Q1 2026 - Operating income fell despite higher sales, but recovery is expected in 2H.4118
Q2 2026 - Net income rose despite flat sales, driven by Health Care, Nutrition, and innovation.4118
Q3 2026 - Record sales and net income, with FY2026 guidance for further growth and higher dividends.4118
Q4 2026 - Record-high sales and profits across all segments, with robust outlook amid global volatility.4118
Q1 2027